BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2013
View Archived Issues
Biogen presents novel AAV-virus derived mouse models of neurodegenerative disorders
Read More
Clinical data on GS-9973 alone and in combination with idelalisib reported
Read More
InDex Pharmaceuticals completes patient recruitment in phase III Kappaproct trial
Read More
TP-0413 as therapy for treating anemia of chronic disease
Read More
Encouraging phase I study results reported for LPCN-1111
Read More
ASP-9133 shows improved potency and selective inhibition of bronchoconstriction
Read More
Bavarian Nordic plans interim analysis of PROSPECT trial
Read More
GSK and A*STAR's ICES to develop evidence-based formulations
Read More
New tool for predicting progression of mild cognitive impairment to Alzheimer's disease
Read More
Improving diagnosis via the discovery of biomarker ligands in patients with NMO
Read More
Gilead Sciences submits NDA for sofosbuvir
Read More
Sarepta reports results from extension study of eteplirsen in Duchenne muscular dystrophy
Read More
PredictAD tool proves useful for AD conversion
Read More
Viralytics planning phase I/II study of Cavatak following phase I results
Read More
EyeGate Pharma reports topline data from phase III study in anterior uveitis
Read More
Vaxil BioTherapeutics reports results from phase I/II ImMucin trial
Read More
Pfizer to launch Ameparomo for intestinal amebiasis in Japan
Read More
Eisai discloses novel chemokine receptor antagonists
Read More
Merck & Co. reports novel agents for HCV infection
Read More
Scientists at Merck KGaA disclose novel p70S6K inhibitors
Read More
Novartis prepares new CFTR activators
Read More
RVX-2135 shows promise in AML cell lines
Read More
Stem Cell Therapeutics completes merger with Trillium Therapeutics
Read More
Lipid Therapeutics files IND for LT-02
Read More
Topline results reported from phase II study of RP-5063
Read More